ALB and familial pancreatic carcinoma: Fan et al. (23) compared the combination of six inflammatory markers, namely neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), C-reactive protein/albumin ratio (CAR), neutrophil/albumin ratio (NAR), platelet/albumin ratio (PAR), and C-reactive protein/lymphocyte ratio (CLR) to predict the accuracy of poor survival rate of pancreatic cancer, and found that CLR was more accurate than NLR, PLR, CAR, NAR and PAR in predicting the survival rate of pancreatic cancer.